|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| C07K 14/54 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 3762015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19764856.1 |
| Date of filing the European patent application | 2019-03-04 | |
| (97) | Date of publication of the European application | 2021-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-24 |
| (46) | Date of publication of the claims translation | 2026-03-25 |
| (86) | Number | PCT/IB2019/051732 |
| Date | 2019-03-04 |
| (87) | Number | WO 2019/171252 |
| Date | 2019-09-12 |
| (30) | Number | Date | Country code |
| 201862638624 P | 2018-03-05 | US |
| (72) |
CHAN, Daphne , US
ADEDOKUN, Omoniyi , US
CHEN, Yang , US
SZAPARY, Philippe , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Guselkumabas, skirtas Krono ligai gydyti, su dozavimo režimu |
| GUSELKUMAB FOR USE IN THE TREATMENT OF CROHN'S DISEASE WITH A DOSAGE REGIMEN |
| Payment date | Validity (years) | Amount | |
| 2026-02-26 | 8 | 185.00 EUR |
| 2027-03-04 |